Author:
Liu Gordon G.,Guan Haijing,Peng Nan,Xie Shitong,Wang Kang,Liu Larry Z.,Zhou Yanbing,Jin Huajie
Funder
National Natural Science Foundation of China
Reference46 articles.
1. The new definition of health technology assessment: a milestone in international collaboration;O’Rourke;Int J Technol Assess Health Care,2020
2. The role of stakeholder involvement in the evolving EU HTA process: insights generated through the European Access Academy’s multi-stakeholder pre-convention questionnaire;Van Haesendonck;J Mark Access Health Policy,2023
3. Recent pricing negotiations on innovative medicines pilot in China: experiences, implications, and suggestions;Li;Value Health Reg Issues,2018
4. Use of health technology assessment in drug reimbursement decisions in China;Chen;BMJ,2023
5. Informing a cost-effectiveness threshold for health technology assessment in China: a marginal productivity approach;Ochalek;Pharmacoeconomics,2020